IQVIA Holdings Inc.
IQV
Key stats
- Open
- 277.44
- Day high
- 277.44
- Day low
- 266.23
- Previous close
- 274.53
- Volume
- 1.04M
- VWAP
- 271.01
- 52-week high
- 284.50
- 52-week low
- 154.50
- Market cap
- 45.24B
- Shares out
- 164.80M
- Employees
- 95,000
- Listed
- 2013
About IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · DURHAM, NC · iqvia.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 5.4K
- Put open interest
- 3.2K
- Put/call
- 0.60
- At-the-money IV
- 42.7%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 290 call | 2.10 | Nov 11, 3:23 PM | 64 | 412 | 42.5% |
| 270 call | 7.26 | Nov 12, 1:03 PM | 25 | 394 | 42.7% |
| 280 put | 8.75 | Nov 11, 3:56 PM | 21 | 419 | 39.7% |
| 300 call | 0.35 | Nov 12, 11:35 AM | 9 | 1.1K | 52.5% |
| 240 put | 0.24 | Nov 11, 12:29 PM | 9 | 574 | 52.6% |
| 250 call | 28.53 | Nov 11, 2:26 PM | 4 | 299 | 42.2% |
Quarterly results
Massive · Oct 27, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $4.43B | $4.37B | $4.15B | $4.36B |
| Gross profit | $1.50B | $1.44B | $1.35B | $1.44B |
| Operating income | $572.00M | $506.00M | $514.00M | $627.00M |
| Net income | $350.00M | $256.00M | $274.00M | $514.00M |
| Diluted EPS | 2.10 | 1.53 | 1.61 | 2.99 |
| Operating cash flow | $825.00M | $558.00M | $618.00M | $735.00M |
| Assets | $30.47B | $29.88B | $29.68B | $29.94B |
| Liabilities | $23.68B | $23.58B | $23.33B | $23.31B |
| Equity | $6.79B | $6.30B | $6.35B | $6.63B |
Technicals
Massive · Nov 12, 2026- 50-day average267.54
- 200-day average210.88
- RSI (14 days)51.9
Short interest
Massive · Oct 30, 2026- Oct 30, 20263.04M shares · 2.1 days to cover
- Oct 15, 20262.99M shares · 2.4 days to cover
- Sep 30, 20263.22M shares · 1.7 days to cover
- Sep 15, 20264.12M shares · 3.0 days to cover
Related companies
MassiveNews coverage
No stories about IQVIA Holdings Inc. right now.